SCHEMBL1700765

SCHEMBL1700765

Cc1cc(C)[nH]c(=O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29943510 0.77 — —
SCHEMBL18701493 0.75 CA1 (0.43) —
SCHEMBL3995513 0.74 — —
SCHEMBL2962199 0.74 — —
SCHEMBL11929402 0.74 — —
SCHEMBL25112082 0.74 — —
SCHEMBL1092933 0.74 — —
SCHEMBL24818436 0.74 — —
SCHEMBL589096 0.74 — —
SCHEMBL2884356 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114409636-B Quinazolinone compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof 沈阳药科大学 2023-04-18 — — CN claimed
US-20250311689-A1 SEEDLING GERMINATION AND GROWTH CONDITIONS PIONEER HI-BRED INTERNATIONAL, INC. (US) 2025-10-09 — — US disclosed
US-12344618-B2 Heterotricyclic derivative compound and use of same HANMI PHARMACEUTICAL CO., LTD. (KR) 2025-07-01 — — US disclosed
CN-119698422-A Aza condensed ring compound, preparation method and medical application thereof 苏州爱科百发生物医药技术有限公司 2025-03-25 — — CN disclosed
US-20240217952-A1 TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN POSEIDON INNOVATION 1, INC. 2024-07-04 — — US disclosed
WO-2024067660-A1 AZA-FUSED RING COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE 苏州爱科百发生物医药技术有限公司 2024-04-04 — — WO disclosed
EP-3356345-B1 HETEROARYL DERIVATIVES AS SEPIAPTERIN REDUCTASE INHIBITORS MAX PLANCK GESELLSCHAFT (DE) 2023-11-08 — — EP disclosed
CN-116888100-A High-activity HPK1 kinase inhibitor 杭州阿诺生物医药科技有限公司 2023-10-13 — — CN disclosed
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 — — WO disclosed
CN-114409636-B Quinazolinone compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof 沈阳药科大学 2023-04-18 — — CN disclosed
US-7553809-B2 Fc receptor modulators and uses thereof ILEXUS PTY LIMITED (AU) 2009-06-30 — — US disclosed
US-7189855-B2 Process for production of phenoxy-substituted 2-pyridone compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-13 — — US disclosed
US-7189855-B2 Process for production of phenoxy-substituted 2-pyridone compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-13 — — US disclosed
US-7189855-B2 Process for production of phenoxy-substituted 2-pyridone compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-13 — — US disclosed
US-20050154210-A1 Process for production of phenoxy-substituted 2-pyridone compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-07-14 — — US disclosed
EP-1538145-A1 PROCESS FOR PRODUCTION OF PHENOXY-SUBSTITUTED 2-PYRIDONE COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 — — EP disclosed
US-4451469-A Selected 6-alkyl-and 4,6-dialkyl-2(1H)-pyridinones as cardiotonics STERLING DRUG INC. (US) 1984-05-29 — — US disclosed
US-4205174-A Process for the production of 6-substituted 4-methyl-2-pyridones LONZA, LTD. (CH) 1980-05-27 — — US disclosed
US-3968118-A Process for the manufacture of 1-hydroxy-2-pyridones HOECHST AKTIENGESELLSCHAFT (DT) 1976-07-06 — — US disclosed
US-3957997-A Anticoccidial complexes of 4,4'-dinitrocarbanilides MERCK & CO., INC. (US) 1976-05-18 — — US disclosed
Send feedback